Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia.
Yoshida N.
Int J Hematol. 2024 Mar;119(3):240-247. doi: 10.1007/s12185-023-03564-4. Epub 2023 Mar 3.
Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.
Grim A, Veiga KR, Saad N.
Rheum Dis Clin North Am. 2023 Nov;49(4):773-787. doi: 10.1016/j.rdc.2023.06.004. Epub 2023 Aug 1.
Bortezomib combined with standard induction chemotherapy in Japanese children with refractory acute lymphoblastic leukemia.
Iguchi A, Cho Y, Sugiyama M, Terashita Y, Ariga T, Hosoya Y, Hirabayashi S, Manabe A, Hara K, Aiba T, Shiokawa T, Tada H, Sato N.
Int J Hematol. 2017 Aug;106(2):291-298. doi: 10.1007/s12185-017-2235-z. Epub 2017 Apr 11.
Marrow failure.
Bagby GC, Lipton JM, Sloand EM, Schiffer CA.
Hematology Am Soc Hematol Educ Program. 2004:318-36. doi: 10.1182/asheducation-2004.1.318.
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies.
Frigault MJ, Graham CE, Berger TR, Ritchey J, Horick NK, El-Jawahri A, Scarfò I, Schmidts A, Haradhvala NJ, Wehrli M, Lee WH, Parker AL, Wiggin HR, Bouffard A, Dey A, Leick MB, Katsis K, Elder EL, Dolaher MA, Cook DT, Chekmasova AA, Huang L, Nikiforow S, Daley H, Ritz J, Armant M, Preffer F, DiPersio JF, Nardi V, Chen YB, Gallagher KME, Maus MV.
Blood. 2024 Sep 12;144(11):1153-1167. doi: 10.1182/blood.2024024104.
Single Large-Scale Mitochondrial DNA Deletion Syndromes.
Goldstein A, Falk MJ.
2003 Dec 17 [updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.
Wang W, Liu L, Hui X, Wang Y, Ying W, Zhou Q, Hou J, Yang M, Sun B, Sun J, Wang X.
BMC Immunol. 2021 Mar 17;22(1):19. doi: 10.1186/s12865-021-00411-1.
Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
Yang X, Luo C, Qian J, Huang X, Zhang J, Wang J, Luo C, Qin X, Li B, Chen J.
Front Immunol. 2023 Sep 6;14:1219872. doi: 10.3389/fimmu.2023.1219872. eCollection 2023.
The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review.
Marrapodi MM, Mascolo A, Roberti D, Martino MD, Rafaniello C, Riccardi C, Rossi F.
Front Pediatr. 2023 Apr 24;11:1149718. doi: 10.3389/fped.2023.1149718. eCollection 2023.
Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology.
Gentet JC, Patte C, Quintana E, Bergeron C, Rubie H, Pein F, Demaille MC, Philip T, Raybaud C.
J Clin Oncol. 1990 Apr;8(4):661-5. doi: 10.1200/JCO.1990.8.4.661.
